Gain Therapeutics, Inc. (GANX)
2.01
+0.20
(+11.05%)
USD |
NASDAQ |
Jan 20, 16:00
2.01
0.00 (0.00%)
After-Hours: 17:36
Gain Therapeutics Price: 2.01 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CEL-SCI Corp. | 5.37 |
| AIM ImmunoTech, Inc. | 1.175 |
| IGC Pharma, Inc. | 0.2802 |
| NovaBay Pharmaceuticals, Inc. | 6.55 |
| Protalix Biotherapeutics, Inc. | 2.045 |
Price Related Metrics
| Price to Book Value | 12.33 |
| Earnings Yield | -31.81% |
| Market Cap | 72.84M |